Related Experiment Videos
Temporal profile of release of interleukin-1beta in neurotrauma
K Fassbender1, S Schneider, T Bertsch
1Department of Neurology, University Clinic Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68135, Mannheim, Germany. fass@neuro.ma.uni-heidelberg.de
Insights
Trauma rapidly releases interleukin-1beta (IL-1beta) in the central nervous system (CNS) within an hour. This early IL-1beta release, detected via mRNA before protein, orchestrates inflammatory responses.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Interleukin-1beta (IL-1beta) is a key inflammatory mediator.
- Its early release kinetics in central nervous system (CNS) trauma are not well understood.
Purpose of the Study:
- To analyze the timing and extent of trauma-induced IL-1beta release in CNS extracellular fluid.
- To investigate the role of IL-1beta in early neuroinflammatory responses.
Main Methods:
- In vivo microdialysis was used to collect brain tissue perfusates.
- Analysis included detection of IL-1beta mRNA and protein.
- The impact of drugs targeting mononuclear phagocytes was assessed.
Main Results:
- A significant release of IL-1beta was detected in CNS extracellular fluid within 60 minutes post-trauma.
- At this early stage, IL-1beta mRNA was present, but the protein was not detected.
- Extracellular IL-1beta protein concentrations peaked at day 2 and then declined.
- Modulation of mononuclear phagocytes affected IL-1beta secretion.
Conclusions:
- The CNS exhibits rapid, early release of IL-1beta following trauma.
- This acute release, preceding protein detection, may initiate the inflammatory cascade.
- IL-1beta acts as a crucial orchestrator in the early neuroinflammatory response to injury.
Abstract:
Timing and extent of trauma-induced release of interleukin-1beta (IL-1beta) in extracellular fluid of the CNS were analyzed. In brain tissue perfusates obtained by in vivo microdialysis a marked release of IL-1beta was unexpectedly detected within less than 60 min. At such an early stage of neurotrauma, mRNA expression of IL-1beta was detected whereas immunoreactivity for the IL-1beta protein was negative. Concentrations of extracellularly secreted IL-1beta protein gradually increased, peaked at day 2 and decreased thereafter. Drugs acting on mononuclear phagocytes significantly modulated IL-1beta secretion. This so far unrecognized acuity of IL-1beta release demonstrated here, may represent a precondition for the orchestrating role of this mediator in the cascade of inflammatory host response.